Fund Holdings — TFG Asset Management GP Ltd

Total Portfolio Value
$614.32M
Total Bought
$141.85M
Total Sold
$38.48M
Net Transaction
+$103.37M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
UIPATH INC(PATH)25,207,62830,950,000+5,742,372279,805336,42754.76%+56,622
ALKAMI TECHNOLOGY INC(ALKT)0600,284+600,284010,8771.77%+10,877
DEFINIUM THERAPEUTICS INC(DFTX)199,994286,990+86,9963,78013,5002.20%+9,720
RELAY THERAPEUTICS INC(RLAY)181,543570,311+388,7681,80610,6711.74%+8,864
MBX BIOSCIENCES INC(MBX)145,480203,543+58,0634,34311,2361.83%+6,893
CELCUITY INC(CELC)064,110+64,11006,7071.09%+6,707
SILENCE THERAPEUTICS PLC(SLN)630,161764,256+134,0953,3218,3921.37%+5,071
IONIS PHARMACEUTICALS INC(IONS)41,76497,173+55,4093,1367,7051.25%+4,569
IMMUNOVANT INC(IMVT)218,507255,934+37,4275,4289,8611.61%+4,433
ALKERMES PLC(ALKS)159,791189,979+30,1885,6509,9541.62%+4,304
HARMONY BIOSCIENCES HLDGS IN(HRMY)119,340201,036+81,6963,3437,3201.19%+3,977
PHARVARIS N V
COM
221,611295,627+74,0166,26110,2231.66%+3,962
DYNE THERAPEUTICS INC(DYN)258,132356,657+98,5254,6807,9211.29%+3,241
CUE BIOPHARMA INC(CUE)093,819+93,81902,9610.48%+2,961
ARROWHEAD PHARMACEUTICALS IN(ARWR)127,198130,484+3,2867,97510,6361.73%+2,660
KRYSTAL BIOTECH INC(KRYS)19,66819,66805,0817,3101.19%+2,229
ACLARIS THERAPEUTICS INC(ACRS)0400,000+400,00002,1160.34%+2,116
AUTOLUS THERAPEUTICS LTD(AUTL)9,500,0009,500,000013,11015,2002.47%+2,090
AGIOS PHARMACEUTICALS INC(AGIO)164,839205,579+40,7405,5777,6291.24%+2,053
MONTE ROSA THERAPEUTICS INC(GLUE)056,052+56,05201,3560.22%+1,356
LYFT INC(LYFT)1,000,0001,000,000013,30014,6102.38%+1,310
SNOWFLAKE INC(SNOW)10,00010,00001,5082,5450.41%+1,037
ACADIA PHARMACEUTICALS INC144,620167,875+23,2553,2194,2470.69%+1,028
AMYLYX PHARMACEUTICALS INC(AMLX)317,877297,926-19,9514,4185,3510.87%+932
CELLDEX THERAPEUTICS INC NEW(CLDX)312,316290,441-21,8759,90710,8071.76%+901
TECTONIC THERAPEUTIC INC(TECX)37,58846,516+8,9281,1621,5990.26%+437
ANNEXON INC(ANNX)1,292,4551,242,455-50,0007,1607,0941.15%-66
KARYOPHARM THERAPEUTICS INC(KPTI)52,9840-52,9842950—-295
ULTRAGENYX PHARMACEUTICAL IN(RARE)39,4730-39,4738270—-827
AARDVARK THERAPEUTICS INC316,6210-316,6211,1940—-1,194
NEKTAR THERAPEUTICS(NKTR)103,03786,996-16,0417,4146,0730.99%-1,340
SPRINKLR INC(CXM)2,200,0002,200,000013,20011,3521.85%-1,848
MAPLIGHT THERAPEUTICS INC(MPLT)112,1150-112,1152,2790—-2,279
WORKIVA INC(WK)250,000250,000014,90812,1281.97%-2,780
AXSOME THERAPEUTICS INC.(AXSM)20,0590-20,0593,3900—-3,390
SOLENO THERAPEUTICS INC102,1250-102,1253,4190—-3,419
KOLIBRI GLOBAL ENERGY INC(KGEI)6,834,5046,834,504037,52133,8455.51%-3,676
PRAXIS PRECISION MEDICINES I(PRAX)15,9520-15,9525,1400—-5,140
WARNER BROS DISCOVERY INC(WBD)923,725250,000-673,72525,3656,6651.08%-18,700
Page 1 of 1
TFG Asset Management GP Ltd — 13F Holdings — Q2 2026 | TickerTrail